Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Savara Inc | mstx-ex321_9.htm |
| EX-31.2 - EX-31.2 - Savara Inc | mstx-ex312_8.htm |
| EX-31.1 - EX-31.1 - Savara Inc | mstx-ex311_10.htm |
| EX-23.1 - EX-23.1 - Savara Inc | mstx-ex231_6.htm |
| EX-21.1 - EX-21.1 - Savara Inc | mstx-ex211_7.htm |
| EX-10.50 - EX-10.50 - Savara Inc | mstx-ex1050_400.htm |
| EX-10.49 - EX-10.49 - Savara Inc | mstx-ex1049_401.htm |
| EX-10.48 - EX-10.48 - Savara Inc | mstx-ex1048_402.htm |
| EX-10.40 - EX-10.40 - Savara Inc | mstx-ex1040_153.htm |
| EX-10.7 - EX-10.7 - Savara Inc | mstx-ex107_639.htm |
| EX-4.8 - EX-4.8 - Savara Inc | mstx-ex48_638.htm |
| 10-K - 10-K - Savara Inc | mstx-10k_20161231.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S‑3 (Nos. 333-202960, 333-188870, 333-174203, 333-164177, 333-133824, 333-127857 and 333-117022) and the Registration Statements on Form S-8 (Nos. 333-126551, 333-151903, 333-174940, 333-190376, 333-198046 and 333-206330) of Mast Therapeutics, Inc. of our report dated March 14, 2016 relating to the financial statements, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
San Diego, California
March 6, 2017